Cadrenal Therapeutics (CVKD) Total Non-Current Liabilities (2022 - 2023)
Cadrenal Therapeutics (CVKD) posted Total Non-Current Liabilities of -$3.55 million for Q4 2023, compared with $1.95 million a year earlier.
Analysis
Cadrenal Therapeutics (CVKD) Total Non-Current Liabilities (2022 - 2023) Analysis & Trends
- In prior years, Cadrenal Therapeutics' Total Non-Current Liabilities was $1.95 million in FY2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,166.70 Bn | 1,135.28 Bn | 19.71 Bn | 60.66 Bn |
| 2 | Johnson & Johnson | 633.99 Bn | 552.52 Bn | 17.26 Bn | 105.50 Bn |
| 3 | AbbVie | 502.96 Bn | 476.07 Bn | 12.70 Bn | 106.45 Bn |
| 4 | Merck | 377.09 Bn | 331.47 Bn | 12.21 Bn | 80.25 Bn |
| 5 | Novartis Ag | 303.78 Bn | 267.77 Bn | 11.24 Bn | 48.34 Bn |
| 6 | Astrazeneca | 266.66 Bn | 240.35 Bn | 12.86 Bn | 33.91 Bn |
| 7 | Amgen | 241.39 Bn | 196.79 Bn | 7.24 Bn | 78.66 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | 35.10 Bn |
| 9 | Pfizer | 172.37 Bn | 119.01 Bn | 10.94 Bn | 97.04 Bn |
| 10 | Cadrenal Therapeutics | 3.09 Mn | -9.53 Mn | - | - |
API Access
Cadrenal Therapeutics Total Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=CVKD&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-non-current-liabilities", "ticker": "CVKD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=CVKD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();